Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain, Postoperative × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 15 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Prostatic Neoplasms 4 Melanoma 4 Lung Neoplasms 4 Solid Tumor 3 Neoplasm Metastasis 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Glioma 2 Gastrointestinal Stromal Tumors 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Choledochal Cyst 2 Carcinoma 2 Anxiety Disorders 2 Advanced Solid Tumor 2 Advanced Malignancies 2 cMET-dysregulated Advanced Solid Tumors 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Terminal Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumour 1 Solid Tumors, KRAS Mutation 1

Interventions

Bupivacaine 24 Saline Solution 17 Dexmedetomidine 17 Ropivacaine 15 Ketamine 10 Sodium Chloride 9 Morphine 9 Lidocaine 9 Acetaminophen 9 Pregabalin 8 Control Groups 8 Injections, Epidural 5 Surgical Procedures, Operative 4 Anesthesia, General 4 parecoxib 3 oxycodone-acetaminophen 3 Tea 3 Ketorolac 3 Gabapentin 3 Fentanyl 3 Esketamine 3 Epinephrine 3 Dexamethasone 3 Dental Occlusion 3 Anesthetics, Local 3 Vitamins 2 Sufentanil 2 Parapsychology 2 Methadone 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06315634 2024-03-18

Intrathecal Dexmedetomidine vs Midazolame

National Cancer Institute, Egypt

Phase 4 Completed

Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡